FDA Inspection 1307434 — UPMC Harrisburg

UPMC Harrisburg — FEI 2571908

The FDA completed an inspection of UPMC Harrisburg on March 10, 2026 in Harrisburg, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 10, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Harrisburg, PA (United States)